Applicant, as named in the Orange Book
Onyx Pharms Amgen
Next listed expiry: Kyprolis on 29 Oct 2041. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Ingredient | NDA | Earliest generic entry | Basis |
|---|
| Kyprolis · 3 strengths carfilzomib | carfilzomib | 202714 | 29 Oct 2041 | patent |
Recent events
- 25 Oct 2026Kyprolis · Generic tentatively approved 7 Nov 2025
- 25 Oct 2026Kyprolis · Generic approved 20 Jul 2026